The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Headline
Nominations are being accepted until March 31 for the 2027 class of the AHA Next Generation Leaders Fellowship. Hospitals and health systems are encouraged to…
Perspective
Public
The grace, beauty and breathtaking athleticism on display during the just-concluded Winter Olympics reminds us that excellence is achieved in steps and earned…
Headline
The Maine Hospital Association recently announced that longtime President Steven Michaud is retiring and will be succeeded by Jeffrey Austin, MHA vice…
Chairperson's File
Public
Marc Boom, M.D., is president and CEO of Houston Methodist, which includes a leading academic medical center in the Texas Medical Center with seven other…
Blog
Public
Hannah Nesich, AHA senior communications specialist, recently sat down with Joy Rhoden, AHA senior vice president and executive director, health outcomes and…
Perspective
Public
In the beloved holiday movie classic “It’s a Wonderful Life,” unassuming everyman George Bailey learns the profound lesson that his life — and all lives —…